在阿尔茨海默氏症患者的大脑中报告的蛋白质变化的汇编
Manor Askenazi1, Tomas Kavanagh2, Geoffrey Pires3
1Biomedical Hosting LLC, Arlington, MA, 02140, USA.
Nature communications
|July 25, 2023
概括
这项研究绘制了阿尔茨海默氏症的地图.
科学领域:
- 神经科学是一个神经科学.
- 蛋白质组学是指蛋白质组学.
- 生物化学 生物化学
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,其特点是逐渐认知能力下降.
- 识别AD大脑中的分子变化对于理解疾病机制和开发治疗方法至关重要.
- 蛋白质组学研究提供了一种高通量方法,用于对AD的蛋白质变化进行分类.
研究的目的:
- 系统地分析和合成已发表的阿尔茨海默病蛋白质组学研究的发现.
- 创建一个全面地图的蛋白质改变在不同的大脑区域,疾病的阶段,和病理的标志.
- 确定持续改变的蛋白质作为潜在的生物标记物和阿尔茨海默病的治疗点.
主要方法:
- 对38项已发表的关于人类阿尔茨海默病大脑组织的蛋白质学研究的元分析.
- 将数据编译成一个可搜索的数据库 (NeuroPro).
- 分析了13个大脑区域,三个疾病阶段和特定病理蛋白质聚合物的蛋白质变化.
主要成果:
- 在5个或更多的研究中确定了848种蛋白质,这些蛋白质在5个或更多的研究中得到了持续的改变.
- 在阿尔茨海默氏病的早期,突触,囊泡和 lysosomal 途径蛋白质被改变.
- 在晚期阿尔茨海默病中观察到广泛的线粒体蛋白质表达变化.
- 蛋白质变化在脆弱和耐药的大脑区域之间显示出相似性.
结论:
- 这一全面的分析为了解阿尔茨海默氏病大脑蛋白质组提供了宝贵的资源.
- 早期的AD的特点是突触和溶酶体通路的改变.
- 线粒体功能障碍在阿尔茨海默病晚期阶段变得突出.
- 鉴定到的蛋白质需要进一步研究,作为潜在的诊断标记物和阿尔茨海默病的治疗点.
更多相关视频
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
12.0K
11:49Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
Published on: August 28, 2021
4.5K
相关概念视频
Alzheimer's Disease: Overview
524
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
524
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
